Dose-finding Study Using Pentostatin for Injection in the Treatment of Steroid-refractory aGvHD

NCT00032773 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Graft Versus Host Disease

Interventions

DRUG: pentostatin for injection

Sponsor

Astex Pharmaceuticals, Inc.